⌘K

Home/Filings/4/0001179110-07-019304

4//SEC Filing

ALBANY MOLECULAR RESEARCH INC 4

Accession 0001179110-07-019304

CIK 0001065087operating

View on SEC.gov Company Profile

Filed

Oct 2, 8:00 PM ET

Accepted

Oct 3, 1:16 PM ET

Size

9.6 KB

Accession

0001179110-07-019304

Insider Transaction Report

Form 4

Period: 2007-10-02

ALBANY MOLECULAR RESEARCH INCAMRI

Evans Johnathan D

VP Pharma Dev & Manu

Transactions

Award
Option to purchase Common Stock
2007-10-02$15.99/sh+18,000$287,820→ 18,000 total
Exercise: $15.99From: 2010-10-02Exp: 2017-10-02→ Common Stock (18,000 underlying)
Award
Option to purchase Common Stock
2007-10-02$15.99/sh+6,000$95,940→ 24,000 total
Exercise: $15.99From: 2011-10-02Exp: 2017-10-02→ Common Stock (6,000 underlying)

Documents

1 file

4
edgar.xmlPrimary
FORM 4 -

Issuer

ALBANY MOLECULAR RESEARCH INC

CIK 0001065087

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001065087

Filing Metadata

Form type: 4
Filed: Oct 2, 8:00 PM ET
Accepted: Oct 3, 1:16 PM ET
Size: 9.6 KB

View on SEC.gov